STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher 

The FDA has rejected a rare disease therapy from Disc Medicine. Disc Medicine is noted as an early recipient of a commissioner's voucher from the agency.